Navigation Links
Allscripts Reports Fourth Quarter 2007 Results
Date:2/13/2008

Company Posts Record Revenue and Earnings per Share for the Year

CHICAGO, Feb. 13 /PRNewswire-FirstCall/ -- Allscripts, the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare, today announced results for the three months and year ended December 31, 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b)

Total revenue for the three months ended December 31, 2007 was $73.4 million, compared to $63.6 million for the same period last year. Revenue from software and related services for the three months ended December 31, 2007 was $57.8 million, compared to $48.9 million for the same period last year, increasing by 18.1%. Gross margin percentage was 48.9% for the fourth quarter of 2007, compared to 53.5% during the fourth quarter of 2006.

Net income for the three months ended December 31, 2007 was $5.9 million, or $0.10 per diluted share, compared to net income of $4.5 million, or $0.08 per diluted share, for the same period last year. Non-GAAP adjusted earnings for the three months ended December 31, 2007 were $8.5 million, or $0.14 per diluted share, compared to non-GAAP adjusted earnings of $6.6 million, or $0.11 per diluted share for the same period last year. Non-GAAP adjusted earnings for the three months ended December 31, 2007 and 2006 are comprised of net income giving effect to the add-back of acquisition-related amortization of $1.6 million or $0.03 per diluted share for both reported periods, net of tax, and total stock-based compensation expense of $0.9 million and $0.6 million, respectively, or $0.01 per diluted share for both reported periods, net of tax. Please see "Explanation of Non-GAAP Financial Measures" below for a discussion of non-GAAP adjusted earnings and earnings per share.

As of December 31, 2007 the Company had cash and mar
'/>"/>

SOURCE Allscripts
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Mankato Clinic Selects Allscripts Electronic Health Record
2. ProHealth Physicians Selects Allscripts Electronic Health Record and Practice Management for 240 Providers
3. Allscripts Adds TeamPraxis Quality Reporting Software for Electronic Health Records
4. Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report
5. Allscripts Reports Third Quarter 2007 Results
6. Allscripts to Announce Third Quarter 2007 Results on November 8th
7. Lakeside Systems Selects Allscripts Electronic Health Record for 100 Physicians
8. Allscripts Featured in Microsoft HealthVault Worldwide Launch
9. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
10. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
11. Allscripts Named to FORTUNE 100 Fastest-Growing Companies List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... (PRWEB) March 05, 2015 Supply & ... annual listing of “Pros to Know” in the supply ... two members of MEBC’s leadership team were included on ... nominated and received this award due to their hard ... innovative methods for meeting and resolving client needs and ...
(Date:3/5/2015)... March 05, 2015 As a ... (AAPA) review of Clearstream, LLC ’s products, ... Clearstream’s MediDefense line of products—led by their mPulse ... Affinity Partner Program. , The AAPA—which represents a ... all medical and surgical specialties in the U.S.—advocates ...
(Date:3/5/2015)... Park, California (PRWEB) March 05, 2015 ... (JCAP) last week released a special issue ... in the field of PANDAS (Pediatric Autoimmune Neuropsychiatric ... Neuropsychiatric Syndromes), an autoimmune reaction triggered by infections ... lyme, which result in inflammation of the child's ...
(Date:3/5/2015)... March 05, 2015 Wimbledon Health ... provides vascular, echocardiogram and NCV testing, announced ... the Chief Medical Officer. Dr. Artel will be responsible ... of the WimbledonMED program and the continued growth and ... about working with Wimbledon Health Partners as a consulting ...
(Date:3/5/2015)... March 05, 2015 March 5, 2015 ... off next week (March 8-14, 2015), children’s hospitals around ... play in making hospital stays as safe as possible ... children’s hospitals—Children’s Hospitals’ Solutions for Patient Safety (SPS) and ... for families to follow when visiting the hospital with ...
Breaking Medicine News(10 mins):Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 3Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 2Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 2Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 4
... at the chemical plan in the month of November released toxic ... in Russia also as they share the same water resources. // ... the danger of concentration of these chemicals due to the melting ... test to be carried out in a random fashion to make ...
... the moles which are seen among elderly Australians who run ... dangerous. // The country’s skin specialists believe that this is ... many as 309 patients were studied during the course of ... of the new moles on older patients being melanomas were ...
... a very low calories diet can help the heart age more ... to be the first ever human trial study. // ... demonstrate the cardiac benefits of a restricted calorie diet. ... the Caloric Restriction Society, ages 41 to 64, who consume 1,400 ...
... not feel threatened by the bird flu outbreaks in Turkey, ... reported to have already taken measures// to prevent the spread ... ready to face all possibilities of an outbreak. The Government ... virus. ,Money has already been apportioned by ...
... U.S. Army Medical Research Institute of Infectious Diseases have found ... protection and treatment of humans // from wild strains of ... has to be done as this Ebola virus offers a ... are published in the Journal Public Library of Science Pathogens. ...
... doctors it is imperative that global guidelines for giving iron ... The reason is// that since they might be dangerous ... by researchers from the United States and Tanzania. They called ... severe illness and death if they are given to children ...
Cached Medicine News:Health News:UN Fears Melting Of Ice Would Concentrate Toxins in the Chinese Water Supply 2
(Date:3/5/2015)... March 5, 2015  Relmada Therapeutics, Inc. (OTCQB: ... the treatment of chronic pain, today announced the ... advisory roles. The panel of experts will provide ... efforts to advance the company pipeline of novel ... expertise in a range of areas including opioid ...
(Date:3/5/2015)... 2015 LUNGevity Foundation, the nation,s leading ... Administration,s (FDA) approval of Bristol Myers Squibb,s new ... treatments add another critical new treatment option to ... a patient,s own immune system to fight cancerous ... for patients with squamous cell lung cancer, a ...
(Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... the "Japan Pharma Outlook 2015: Year to Watch ... Initiatives" report to their offering. ... from April -2014 (Annexure 1) is a ... - whether generic or innovator. The most of the ...
Breaking Medicine Technology:Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3
... 2011 Reportlinker.com announces that a new ... catalogue: Pharmaceutical Key Trends ... the pharmaceutical industry ... A number of factors have ...
... Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) today announced ... Administration,s (the "FDA") Division of Oncology Drug Products (the ... New Drug Application (the "NDA") for pixantrone for relapsed ... for accelerated approval based on the PIX301 study results. ...
Cached Medicine Technology:Reportlinker Adds Pharmaceutical Key Trends 2011 Overview - Key strategic trends in the pharmaceutical industry 2Reportlinker Adds Pharmaceutical Key Trends 2011 Overview - Key strategic trends in the pharmaceutical industry 3Reportlinker Adds Pharmaceutical Key Trends 2011 Overview - Key strategic trends in the pharmaceutical industry 4Cell Therapeutics Completes Type A Meeting With FDA's Division of Oncology Drug Products: Guidance Provided for Resubmission of Pixantrone NDA for Consideration of Accelerated Approval 2Cell Therapeutics Completes Type A Meeting With FDA's Division of Oncology Drug Products: Guidance Provided for Resubmission of Pixantrone NDA for Consideration of Accelerated Approval 3Cell Therapeutics Completes Type A Meeting With FDA's Division of Oncology Drug Products: Guidance Provided for Resubmission of Pixantrone NDA for Consideration of Accelerated Approval 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: